Coumarins As Potential Antidiabetic Agents
Overview
Pharmacy
Authors
Affiliations
Objectives: Even with great advances in modern medicine and therapeutic agent development, the search for effective antidiabetic drugs remains challenging. Coumarins are secondary metabolites found widely in nature plants and used mainly in anticoagulation and antithrombotic therapy. Over the past two decades, however, there has been an increasing body of literatures related to the effects of coumarins and their derivatives on diabetes and its complications. This review aimed to focus on research findings concerning the effects of coumarins against diabetes and its complications using in-vitro and in-vivo animal models, and also to discuss cellular and molecular mechanisms underlying these effects.
Key Findings: The search for new coumarins against diabetes and it complications, either isolated from traditional medicine or chemically synthesized, has been constantly expanding. The cellular and molecular mechanisms involved include protecting pancreatic beta cells from damage, improving abnormal insulin signalling, reducing oxidative stress/inflammation, activating AMP-activated protein kinase (AMPK), inhibiting α-glucosidases and ameliorating diabetic complications.
Conclusions: The effects and mechanisms of coumarins and their derivatives upon diabetes and its complications are discussed in current review. Further investigations remain to be carried out to develop a promising antidiabetic agent based on coumarin cores.
Lachowicz-Radulska J, Widelski J, Nowaczynski F, Serefko A, Sobczynski J, Ludwiczuk A Int J Mol Sci. 2025; 26(4).
PMID: 40003910 PMC: 11855297. DOI: 10.3390/ijms26041444.
Saberi-Zare M, Bodaghifard M Sci Rep. 2025; 15(1):3408.
PMID: 39870729 PMC: 11772692. DOI: 10.1038/s41598-025-87779-x.
An Overview on the Synthesis of Lamellarins and Related Compounds with Biological Interest.
Mitsiou V, Antonaki A, Douka M, Litinas K Molecules. 2024; 29(17).
PMID: 39274880 PMC: 11396623. DOI: 10.3390/molecules29174032.
An Overview of the Synthesis of 3,4-Fused Pyrrolocoumarins of Biological Interest.
Kapidou E, Litinas K Molecules. 2024; 29(12).
PMID: 38930816 PMC: 11206682. DOI: 10.3390/molecules29122748.
Bodaghifard M, Pourmousavi S, Ahadi N, Zeynali P Nanoscale Adv. 2024; 6(10):2713-2721.
PMID: 38752148 PMC: 11093261. DOI: 10.1039/d4na00131a.